Sweet News For McNeil: Splenda Health Claim Approved By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is proposing to amend the regulation allowing a health claim on non-cavity-causing sweeteners to allow sucralose, an ingredient included in McNeil Nutritionals' Splenda No-Calorie Sweetener
You may also be interested in...
Omega-3 claims
"Immediate action" to allow nutrient claims for fatty acids "will have significance far beyond the realm of heart disease prevention," the American Institute for Cancer Research maintains in comments to FDA. Claims could encourage consumers to select foods with protective effects, rather than "over-consuming omega-6 fatty acids," which are thought to induce cancer if consumed in excess, AICR says. Separately, Shape Up America! suggests "this action alone could be an important step in reducing the risk for cardiovascular disease, one of the leading co-morbid conditions for obesity"...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands